Oncology & Cancer

FDA approves Padcev for muscle-invasive bladder cancer

The U.S. Food and Drug Administration has approved Pfizer's Padcev (enfortumab vedotin-ejfv), a Nectin-4 directed antibody-drug conjugate, as a perioperative neoadjuvant treatment and postcystectomy adjuvant treatment for ...

Overweight & Obesity

WHO backs GLP-1 treatments to tackle obesity epidemic

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which affects over one billion people worldwide, the World Health Organization said Monday.

page 11 from 40